Akèy › Displazi vantrikil dwat aritmojenik › Kalifòni
Etid klinik pou Displazi vantrikil dwat aritmojenik nan Kalifòni
4 etid pou Displazi vantrikil dwat aritmojenik ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
- University of California, San Diego, La Jolla
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT05885412A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
- Leland Stanford Junior University, Redwood City
Ap rekriteEtid obsèvasyon
Laj 18 a 65 · Tout sèks · Mizajou May 16, 2025 · NCT06976606Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
- University of California San Francisco, San Francisco
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Feb 6, 2025 · NCT06228924Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
- University of California San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 14 a 65 · Tout sèks · Mizajou Nov 1, 2024 · NCT06311708Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.